185 related articles for article (PubMed ID: 32977028)
1. Human-induced pluripotent stem cells as a model for studying sporadic Alzheimer's disease.
Riemens RJM; Kenis G; van den Beucken T
Neurobiol Learn Mem; 2020 Nov; 175():107318. PubMed ID: 32977028
[TBL] [Abstract][Full Text] [Related]
2. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
3. Modelling Sporadic Alzheimer's Disease Using Induced Pluripotent Stem Cells.
Rowland HA; Hooper NM; Kellett KAB
Neurochem Res; 2018 Dec; 43(12):2179-2198. PubMed ID: 30387070
[TBL] [Abstract][Full Text] [Related]
4. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.
Marei HE; Khan MUA; Hasan A
Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028
[TBL] [Abstract][Full Text] [Related]
5. Establishment of induced pluripotent stem cells IRMBi005-A from a patient with sporadic Alzheimer's disease.
Provost CC; Auboyer L; Rovelet-Lecrux A; Monzo C; Schob E; Lehmann S; Wallon D; Crozet C
Stem Cell Res; 2023 Oct; 72():103216. PubMed ID: 37783001
[TBL] [Abstract][Full Text] [Related]
6. Increased GABAergic development in iPSC-derived neurons from patients with sporadic Alzheimer's disease.
Tang Y; Han Y; Yu H; Zhang B; Li G
Neurosci Lett; 2020 Sep; 735():135208. PubMed ID: 32615251
[TBL] [Abstract][Full Text] [Related]
7. Increased susceptibility to Aβ toxicity in neuronal cultures derived from familial Alzheimer's disease (PSEN1-A246E) induced pluripotent stem cells.
Armijo E; Gonzalez C; Shahnawaz M; Flores A; Davis B; Soto C
Neurosci Lett; 2017 Feb; 639():74-81. PubMed ID: 28034781
[TBL] [Abstract][Full Text] [Related]
8. Induced human pluripotent stem cells (HEBHMUi013-A) derived from a patient of sporadic Alzheimer's disease.
Cao S; Guo R; Fu Z; Liu Y; Wu T; Zhou Z; Zhang J; Liu X; Song Y; Ma J
Stem Cell Res; 2023 Apr; 68():103052. PubMed ID: 36870256
[TBL] [Abstract][Full Text] [Related]
9. iPSC-derived cortical neurons to study sporadic Alzheimer disease: A transcriptome comparison with post-mortem brain samples.
Verheijen MCT; Krauskopf J; Caiment F; Nazaruk M; Wen QF; van Herwijnen MHM; Hauser DA; Gajjar M; Verfaillie C; Vermeiren Y; De Deyn PP; Wittens MMJ; Sieben A; Engelborghs S; Dejonckheere W; Princen K; Griffioen G; Roggen EL; Briedé JJ
Toxicol Lett; 2022 Mar; 356():89-99. PubMed ID: 34921933
[TBL] [Abstract][Full Text] [Related]
10. The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer's Disease Modeling.
Lee C; Willerth SM; Nygaard HB
Prog Neurobiol; 2020 Sep; 192():101804. PubMed ID: 32464173
[TBL] [Abstract][Full Text] [Related]
11. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
Machairaki V
Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
[TBL] [Abstract][Full Text] [Related]
12. Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases.
Tcw J
Neurosci Lett; 2019 Apr; 699():31-40. PubMed ID: 30685408
[TBL] [Abstract][Full Text] [Related]
13. Establishment of KEIOi005-A iPSC line from urine-derived cells (UDCs) of a mild Alzheimer's disease (AD) donor with multiple risk SNPs for sporadic Alzheimer's disease (sAD).
Supakul S; Leventoux N; Tabuchi H; Mimura M; Ito D; Maeda S; Okano H
Stem Cell Res; 2022 Jul; 62():102802. PubMed ID: 35537244
[TBL] [Abstract][Full Text] [Related]
14. Limitations of the human iPSC-derived neuron model for early-onset Alzheimer's disease.
Valdes P; Henry KW; Fitzgerald MQ; Muralidharan K; Caldwell AB; Ramachandran S; Goldstein LSB; Mobley WC; Galasko DR; Subramaniam S
Mol Brain; 2023 Nov; 16(1):75. PubMed ID: 37924159
[TBL] [Abstract][Full Text] [Related]
15. Aberrant iPSC-derived human astrocytes in Alzheimer's disease.
Jones VC; Atkinson-Dell R; Verkhratsky A; Mohamet L
Cell Death Dis; 2017 Mar; 8(3):e2696. PubMed ID: 28333144
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
[TBL] [Abstract][Full Text] [Related]
17. Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.
Mungenast AE; Siegert S; Tsai LH
Mol Cell Neurosci; 2016 Jun; 73():13-31. PubMed ID: 26657644
[TBL] [Abstract][Full Text] [Related]
18. Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.
Yang J; Li S; He XB; Cheng C; Le W
Mol Neurodegener; 2016 May; 11(1):39. PubMed ID: 27184028
[TBL] [Abstract][Full Text] [Related]
19. Important advances in Alzheimer's disease from the use of induced pluripotent stem cells.
Majolo F; Marinowic DR; Machado DC; Da Costa JC
J Biomed Sci; 2019 Feb; 26(1):15. PubMed ID: 30728025
[TBL] [Abstract][Full Text] [Related]
20. Modelling mitochondrial dysfunction in Alzheimer's disease using human induced pluripotent stem cells.
Hawkins KE; Duchen M
World J Stem Cells; 2019 May; 11(5):236-253. PubMed ID: 31171953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
